BRAINTREE, Mass., Feb. 6, 2017 /PRNewswire/ -- Haemonetics Corporation
The Company is posting this press release and, additionally, three presentation slides that will
Direct link to Earnings Release FY17 Q3:
Direct link to Three Presentation Slides That Will Be Referenced on the Webcast:
As previously announced, the Company will host a conference call with investors and analysts to discuss and answer questions about the results at 8:00am Eastern Time on February 6, 2017. A live webcast of the call can be accessed on Haemonetics' investor relations website.
Direct link to Conference Call Webcast: http://edge.media-server.com/m/p/s6y9gqek
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.
INVESTOR CONTACT:Gerry Gould, VP-Investor Relations(781) [email protected]
MEDIA CONTACT:Sandra Jesse, Executive VP(781) [email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-3rd-quarter-fiscal-2017-earnings-release-available-on-investor-relations-website-300402192.html
SOURCE Haemonetics Corporation
Subscribe to our Free Newsletters!
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...
Hashimoto's thyroiditis is an autoimmune disorder of the thyroid causing hypothyroidism. Synthetic ...
Strokes occur when blood flow to an area of the brain is cut off. It is imperitive to detect the ...View All